Saswati Hazra, Ph.D.
Affiliations: | 2003 | University of Southern California, Los Angeles, CA, United States |
Area:
Cell BiologyGoogle:
"Saswati Hazra"Parents
Sign in to add mentor| Hidekazu Tsukamoto | grad student | 2003 | USC | |
| (PPARgamma induces a phenotypic switch from activated to quiescent hepatic stellate cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liclican EL, Walser TC, Hazra S, et al. (2014) Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. Cancer Prevention Research (Philadelphia, Pa.). 7: 845-55 |
| Tao JJ, Castel P, Radosevic-Robin N, et al. (2014) Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer. Science Signaling. 7: ra29 |
| Elkabets M, Vora S, Juric D, et al. (2013) mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer. Science Translational Medicine. 5: 196ra99 |
| Liclican EL, Hazra S, Larsen JE, et al. (2013) Abstract A08: The role of miR-125a in the pathogenesis of lung cancer Cancer Prevention Research. 6 |
| Elkabets M, Vora S, Juric D, et al. (2013) Abstract B106: mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer. Molecular Cancer Therapeutics. 12 |
| Hazra S, Lee J, Kim PS, et al. (2012) Profiling of circulating tumor cells isolated from 105 metastatic gastric cancer patients revealed HER2 overexpression/activation for potential use in clinical setting. Journal of Clinical Oncology. 30: 10535-10535 |
| Scaltriti M, Tao J, Juric D, et al. (2012) Abstract 4471: Combined blockade of PI3K/AKT and EGFR/HER3 enhances antitumor activity in triple negative breast cancer. Cancer Research. 73: 4471-4471 |
| Lee G, Gardner BK, Hazra S, et al. (2012) Abstract 2558: VEGF-dependent suppression of prostaglandin transporter (PGT) expression in Kras mutant human bronchial epithelial cells Cancer Research. 72: 2558-2558 |
| Hazra S, Liu L, Webster E, et al. (2012) Abstract 1217: Detection of HER2 expression and phosphorylation in breast cancer CTC samples by CEER™ Cancer Research. 72: 1217-1217 |
| Tao J, Ip P, Auricchio N, et al. (2012) Combined Blockade of PI3K/AKT and EGFR/HER3 Enhances Anti-Tumor Activity in Triple Negative Breast Cancer Cancer Research. 72 |